Eli Lilly is suing four telehealth companies that prescribe compounded versions of the pharmaceutical company's weight loss ...

Obesity medicine experts clear up common misunderstandings and misinformation about these powerful weight loss medications ...

Lexaria Bioscience (LEXX) provides a glucagon-like peptide-1 strategic update following important industry developments reported both by Pfizer ...

Medications like Ozempic and Zepbound work to mimic GLP-1, a hormone that makes you feel full. But there are also ways to ...

Ascletis is taking a low and slow approach to oral GLP-1 dose titration in a phase 2a test after getting a look at clinical ...

After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business ...

Study: Effects of GLP-1 Analogues and Agonists on the Gut Microbiota: A Systematic Review. Image Credit: Corona Borealis Studio/Shutterstock.com Glucagon-like peptide 1 (GLP-1) analogs and ...

GLP-1 drugs are already a success story, making Novo Nordisk, maker of Wegovy and Ozempic, until recently Europe’s highest valued company. However, it appears that the sector is only just getting ...

The In­sti­tute for Clin­i­cal and Eco­nom­ic Re­view, the non­prof­it drug pric­ing watch­dog, re­leased a new re­port on Wednes­day out­lin­ing po­ten­tial fed­er­al pol­i ...

Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access to GLP-1 medications, such as Ozempic and Wegovy, for millions of ...

The family of medications called GLP-1 receptor agonists includes drugs like Wegovy, Zepbound, Ozempic, Mounjaro and Victoza. They were originally developed to treat type 2 diabetes, which happens ...